Overview

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab92939 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Detects a band of approximately 30 kDa (predicted molecular weight: 30 kDa).

Target

  • FunctionRegulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cells adhesion to the substrate in vitro.
  • Sequence similaritiesContains 2 EGF-like domains.
    Contains 1 EMI domain.
  • Cellular localizationSecreted.
  • Information by UniProt
  • Database links
  • Alternative names
    • EGF like domain 7 antibody
    • EGF like domain containing protein 7 antibody
    • EGF like domain multiple 7 antibody
    • EGF-like protein 7 antibody
    • EGFL 7 antibody
    • EGFL7 antibody
    • EGFL7_HUMAN antibody
    • Epidermal growth factor like domain protein 7 antibody
    • Epidermal growth factor-like protein 7 antibody
    • MEGF 7 antibody
    • MEGF7 antibody
    • MGC111117 antibody
    • Multiple EGF like domain protein 7 antibody
    • Multiple EGF-like domains protein 7 antibody
    • Multiple epidermal growth factor like domain protein 7 antibody
    • Multiple epidermal growth factor-like domains protein 7 antibody
    • NEU1 antibody
    • NEU1 protein antibody
    • NOTCH4 like protein antibody
    • NOTCH4-like protein antibody
    • RP11 251M1.2 antibody
    • UNQ187/PRO1449 antibody
    • Vascular endothelial statin antibody
    • VE statin antibody
    • VE-statin antibody
    • ZNEU 1 antibody
    • ZNEU1 antibody
    see all

Anti-EGFL7 antibody images

  • Anti-EGFL7 antibody (ab92939) at 1 µg/ml + Human liver tissue lysate - total protein (ab29889) at 10 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution
    Developed using the ECL technique

    Performed under reducing conditions.

    Predicted band size : 30 kDa
    Observed band size : 30 kDa
    Additional bands at : 110 kDa,90 kDa. We are unsure as to the identity of these extra bands.

    Exposure time : 20 minutes

References for Anti-EGFL7 antibody (ab92939)

ab92939 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab92939.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"